Similar articles

• Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.

  Cantarovich D, Giral M, Josien R, Karam G, Hourmant M, Dantal J, Blancho G, Soulillou JP. Cantarovich D, et al. Transplant Proc. 1995 Feb;27(1):1319. Transplant Proc. 1995. PMID: 7878897 No abstract available.
• Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.

  Bakr MA, Sally S, Foda MA, Sobh MA, el-Sherif AK, Ghoneim MA. Bakr MA, et al. Transplant Proc. 1994 Dec;26(6):3163-6. Transplant Proc. 1994. PMID: 7998104 Clinical Trial. No abstract available.
• Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.

  Hiesse C, Rousseau P, Kriaa F, Larue JR, Charpentier B. Hiesse C, et al. Transplant Proc. 1995 Feb;27(1):1066-7. Transplant Proc. 1995. PMID: 7878807 No abstract available.
• The role of HLA matching for cadaveric renal transplants in the cyclosporine era.

  Hunsicker LG, Held PJ. Hunsicker LG, et al. Semin Nephrol. 1992 Jul;12(4):293-303. Semin Nephrol. 1992. PMID: 1410858 Review. No abstract available.
• Withdrawal of steroids from a cyclosporine-based regimen: pro.

  Ponticelli C. Ponticelli C. Transplant Proc. 1998 Aug;30(5):1782-4. doi: 10.1016/s0041-1345(98)00430-8. Transplant Proc. 1998. PMID: 9723281 Review. No abstract available.